Highbridge Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.31M | Hold |
|
|||||
|
2022
Q3 | $2.51M | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $9.42M | Hold |
|
|||||
|
2020
Q2 | $9.15M | Sell |
|
|||||
|
2020
Q1 | $11.3M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $313K | Sell |
|
|||||
|
2017
Q3 | $2.66M | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2.13M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $89K | Buy |
|